| http://www.w3.org/ns/prov#value | - Physiologically and pharmaceutically acceptable carriers include diluents, fillers, salts buffers, stabilizers, solubilizers, and other materials which are well known in the art. [0070] A preferred embodiment of the invention relates to monoclonal antibodies whose heavy chains comprise in CDR3 the polypeptide PVANIDY, and/or whose light chains comprise in CDR3 the polypeptide QSYDSENPWV and conser
|
